Your browser doesn't support javascript.
loading
Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming.
Vishnoi, Kanchan; Kumar, Sandeep; Ke, Rong; Rana, Ajay; Rana, Basabi.
Afiliação
  • Vishnoi K; Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL 60612, USA.
  • Kumar S; Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL 60612, USA.
  • Ke R; Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL 60612, USA.
  • Rana A; Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL 60612, USA; University of Illinois Hospital & Health Sciences System Cancer Center, The University of Illinois at Chicago, Chicago, IL 60612, USA; Jesse Brown VA Medical Center, Chicago, IL 6
  • Rana B; Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL 60612, USA; University of Illinois Hospital & Health Sciences System Cancer Center, The University of Illinois at Chicago, Chicago, IL 60612, USA; Jesse Brown VA Medical Center, Chicago, IL 6
Curr Opin Pharmacol ; 64: 102232, 2022 06.
Article em En | MEDLINE | ID: mdl-35526340

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article